When we think about the disease called cancer, we tend to think of it as "the result of mutations in genes." Certainly, that is an important explanation. However, if we extend the timeline by hundreds ...
If these drugs are designed to target cancer, why don't they work?Treatments that harness the power of the immune system to ...
Indie favorite Phoebe Bridgers opened her Lost Tour at Gainbridge Fieldhouse Sept. 14, launching a run of arena shows where ...
A platinum-relapsed SCLC patient achieved 16.7 months progression-free survival following Olvi-Vec and platinum rechallenge, exceeding the PFS achieved following platinum-based first-line therapy -- - ...
Obsidian Therapeutics is rated Hold due to overvaluation despite promising cell therapy technology targeting solid tumors.
Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed Imfinzi (durvalumab) plus Amgen's Imdelltra® ...
Amgen (NASDAQ: AMGN) today announced landmark results from the Phase 3 DeLLphi-305 study, which met its primary endpoint at a pre-specified interim analysis, demonstrating a statistically significant ...
The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...
First, a negative DAT does not exclude immune-mediated hemolysis, particularly in ICI-treated patients."BUFFALO, NY — September 10, 2026 — A new case ...
Now in its 16th edition, the report notes that the overall cancer death rate in the US fell 35% between 1991 and 2024—translating to 4.8 million fewer deaths—a decline the report credits to decades of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results